7 insiders buy $1.3 mil of Micro-Cap – Week of 9/10

Investors should always be on the lookout for insights that could give them an edge in the stock market, and one potential source of such information is insider buying activity. When company insiders, such as executives or board members, buy shares of a company’s stock, it can be seen as a vote of confidence in the company’s prospects. Publicly available insider buying information can provide valuable clues about which stocks may be worth considering for investment.

Here are three stocks recently purchased by C-level insiders –

The Beauty Health Company – SYM: SKIN
Recent Price: $6.59
Insider Action: 7 insiders buy $1.3 mil in shares
Description: The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company was founded in 1997 and is headquartered in Long Beach, California.

===
Dividend Expert Reveals His Biggest Income Secrets… Free of Charge

Marc Lichtenfeld – Author of the best-selling book Get Rich With Dividends – is giving away his Ultimate Dividend Package…

Free of charge!

Click Here to Get His #1 Dividend Stock… The Safest 8% Dividend in the World… Top Three “Extreme Dividend” Stocks, And Much, Much More

===

Southland Holdings, Inc. – SYM: SLND
Recent Price: $6.18
Insider Action: 5 insiders buy $214K in shares
Description: Southland Holdings, Inc. engages in specialty infrastructure construction business in North America and internationally. The company operates through two segments, Civil and Transportation. The Civil segment designs and constructs water pipelines, pump stations, lift stations, water and wastewater treatment plants, concrete and structural steel, outfall, and tunneling. The Transportation segment designs and constructs bridges, roadways, marine, dredging, ship terminals and piers, and specialty structures and facilities. Southland Holdings, Inc. was founded in 1900 and is headquartered in Grapevine, Texas.

===
Wanted: 87 People to Beta Test this “8-Month Millionaire” Trading System

The most recent round of Beta Testing could’ve added massive profits to your trading account in just 8 months… Trading expert, Bryan Perry, has tweaked and optimized this system for 3 straight years and is looking for the next group of beta testers to join in and learn this simple trading strategy.

>> Apply here to become one of the 87 new beta testers <<

===

Zimmer Biomet Holdings, Inc.  – SYM: ZBH
Recent Price: $120.65
Insider Action: 5 insiders buy $735K in shares
Description: Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company’s products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopaedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

deal of the month

best growth stocks

Alliance

Bundle package – lifetime subscriptions for all products

Categories

Recent posts

Tags

Connect with Us

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.